Friess Associates LLC Biomarin Pharmaceutical Inc Transaction History

Friess Associates LLC

  • $59.9 Million
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$71.87 - $131.03 $12.3 Million - $22.3 Million
-170,476 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$79.55 - $124.22 $6.79 Million - $10.6 Million
-85,319 Reduced 33.35%
170,476 $21 Million
Q1 2020

May 15, 2020
BUY
$71.37 - $96.85 $14.9 Million - $20.3 Million
209,095 Added 447.74%
255,795 $21.6 Million
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $3 Million - $4.03 Million
46,700 New
46,700 $3.95 Million

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email